Researchers begin study of Ebola vaccine in Africa

Published



WASHINGTON (AP) — The first study of a possible Ebola vaccine is underway in Africa: University of Maryland researchers say three health care workers in Mali received the experimental shots.

The U.S. government developed the vaccine. First-stage human safety testing began last month in the U.S. and Britain. University of Maryland researchers announced the Mali study Thursday as part of that broader safety testing and aim to enroll 40 health workers there.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.